Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in...
Haier Biomedical Terminates Acquisition Plan for Shanghai RAAS
Haier Biomedical (SHA: 688139) has announced the termination of its plan to acquire Shanghai RAAS...
NHSA Revises 2024 NRDL Drug Information Based on Public Feedback
China’s National Healthcare Security Administration (NHSA) has announced revisions to the information about certain drugs...
Eli Lilly China’s Neuroscience VP Jiang Yifei Departs for New Opportunities
Jiang Yifei, the current vice president of Eli Lilly (NYSE: LLY) China’s neuroscience division, has...
Fourier Intelligence Secures USD 109 Million in Series E Funding for Robotics Innovation
China-based Shanghai Fourier Intelligence Co., Ltd, a leading developer of exoskeleton robotic products for rehabilitation...
Astellas’ Padcev and Keytruda Combo Cleared by NMPA for Urothelial Cancer
Japan-based Astellas Pharma Inc. (TYO: 4503) has announced marketing clearance by China’s National Medical Products...
HuidaGene Therapeutics Receives EMA Orphan Designation for HG004 Gene Therapy
Shanghai-based genome medicines specialist HuidaGene Therapeutics has announced a positive opinion from the European Medicines...
China Medical System Licenses Alpha Cognition’s Zunveyl for Dementia Treatment in Asia
China Medical System Holdings (CMS; HKG: 0867) has announced a license agreement with Alpha Cognition...
Huahai Pharmaceutical to Transfer Rights to Innovative Antidepressant HHT001 via Public Listing
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) is set to transfer the patent and...
Mabwell’s 9MW2821 Granted Breakthrough Therapy Designation by CDE for Urothelial Carcinoma
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced that the Center for Drug...
Kelun Pharmaceutical’s Generic Mulpleta Gains NMPA Approval in China
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) has announced that it has received marketing...
Alloy Therapeutics and Sanofi Collaborate on CNS Drug Development with AntiClastic Antisense Platform
US-based Alloy Therapeutics Inc. has announced a target-specific collaboration and license agreement with Sanofi (NASDAQ:...
Fujian Cosunter’s COVID-19 Therapy GST-HG171/ritonavir Approved in Macau
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced that its Category 1 product,...
Medtronic’s Harmony TPV System Gains CE Mark for Minimally Invasive Heart Valve Treatment
US-Irish firm Medtronic (NYSE: MDT) has announced that its Harmony Transcatheter Pulmonary Valve (TPV) System...
Biocytogen and Acepodia Partner to Develop Dual-Payload Bispecific ADCs for Oncology
China’s Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has entered into a partnership with Acepodia,...
Sanofi’s Sarclisa Gains NMPA Approval for Multiple Myeloma Treatment in China
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced that it has received marketing approval from...
Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development
Switzerland-based oncology biotech Araris Biotech AG has announced a research collaboration and option to license...
Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy
US-based Mirror Biologics, Inc., an off-the-shelf immunotherapy developer, has announced a clinical trial collaboration and...
Johnson & Johnson’s Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease
US giant Johnson & Johnson (J&J, NYSE: JNJ) has announced that it has received Fast...
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
US major Boston Scientific Corporation (NYSE: BSX) is set to acquire Bolt Medical, Inc., a...